New system for detecting drug side effects can beat regulatory agencyBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39234.685417.DB (Published 07 June 2007) Cite this as: BMJ 2007;334:1183
- Bob Roehr
- Washington, DC
A new approach to pharmacovigilance developed by doctors in Chicago can identify adverse drug reactions up to six years before the Food and Drug Administration or monitoring programmes run by the drug industry, researchers say (Archives of Internal Medicine 2007;167:1041-9 doi: 10.1001/archinte.167.10.1041).
The scheme, the research on adverse drug events and reports (RADAR) project, was developed by Charles Bennett and colleagues at the Northwestern University Feinberg School of Medicine, in Chicago, and launched in 1998.
Dr Bennett told the BMJ that other pharmacovigilance programmes are based on epidemiology and databases. The RADAR approach is based on considering whether there is a theoretical reason why a drug might have an adverse side …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial